Medpace Holdings Inc.(MEDP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MEDP Medpace Holdings Inc.

盘后交易 03-31 19:19:18 EDT

480.19

+19.89

+4.32%

盘后480.10

-0.09-0.02%

18:53 EDT

最高482.68	最低459.17	成交量32.30万
今开459.17	昨收460.30	日振幅5.11%
总市值136.28亿	流通市值106.70亿	总股本2,838万
成交额1.54亿	换手率1.45%	流通股本2,222万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"MEDP","market":"US","secType":"STK","nameCN":"Medpace Holdings Inc.","latestPrice":480.19,"timestamp":1774987200000,"preClose":460.3,"halted":0,"volume":322965,"hourTrading":{"tag":"盘后","latestPrice":480.1,"preClose":480.19,"latestTime":"18:53 EDT","volume":6934,"amount":3329713.24862,"timestamp":1774997623187,"change":-0.09,"changeRate":-0.000187,"amplitude":0.028301},"delay":0,"changeRate":0.043210949380838554,"floatShares":22220178,"shares":28381283,"eps":15.28,"marketStatus":"盘后交易","change":19.89,"latestTime":"03-31 19:19:18 EDT","open":459.17,"high":482.68,"low":459.17,"amount":154469679.97545,"amplitude":0.051075,"askPrice":524,"askSize":3,"bidPrice":480.2,"bidSize":140,"shortable":3,"etf":0,"ttmEps":15.28,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1775001600000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1470888000000,"exchange":"NASDAQ","adjPreClose":460.3,"preHourTrading":{"tag":"盘前","latestPrice":463.52,"preClose":460.3,"latestTime":"08:43 EDT","volume":4,"amount":1854.08,"timestamp":1774961015990,"change":3.22,"changeRate":0.006995,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":480.1,"preClose":480.19,"latestTime":"18:53 EDT","volume":6934,"amount":3329713.24862,"timestamp":1774997623187,"change":-0.09,"changeRate":-0.000187,"amplitude":0.028301},"volumeRatio":1.272887,"impliedVol":0.5406,"impliedVolPercentile":0.7888},"requestUrl":"/m/hq/s/MEDP","defaultTab":"news","newsList":[{"id":"2610660029","title":"Medpace Holdings, Inc.盘中异动 大幅下跌5.04%报423.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610660029","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610660029?lang=zh_cn&edition=full","pubTime":"2026-02-12 04:33","pubTimestamp":1770841989,"startTime":"0","endTime":"0","summary":"北京时间2026年02月12日04时33分，Medpace Holdings, Inc.股票出现异动，股价急速下跌5.04%。截至发稿，该股报423.56美元/股，成交量49.6074万股，换手率1.75%，振幅4.37%。Medpace Holdings, Inc.股票所在的生命科学行业中，整体跌幅为1.20%。Medpace Holdings, Inc.公司简介：Medpace是一家后期阶段的合同研究组织，为小型和中型生物技术、制药和医疗器械公司提供全方位的药物开发和临床试验服务。全球私募股权公司Cinven于2014年以9.15亿美元收购Medpace，并于2018年退出其投资。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602120433099540cb49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202602120433099540cb49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065170008.USD","LU2065171402.SGD","MEDP","BK4121","BK4585","LU2065171311.SGD","BK4588","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173460357","title":"Zelluna宣布与Medpace达成临床合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1173460357","media":"投资观察","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173460357?lang=zh_cn&edition=full","pubTime":"2026-02-11 15:29","pubTimestamp":1770794996,"startTime":"0","endTime":"0","summary":"Zelluna ASA宣布与Medpace Holdings Inc.建立临床合作伙伴关系。该合作旨在推进双方的临床开发项目，为未来业务拓展奠定基础。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP","LU2065169927.USD","BK4585","BK4121","LU2065170008.USD","LU2065171402.SGD","BK4588","LU2065171311.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113724004","title":"Medpace控股公司将于2026年2月9日公布2025财年第四季度及全年业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1113724004","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1113724004?lang=zh_cn&edition=full","pubTime":"2026-01-06 05:06","pubTimestamp":1767647172,"startTime":"0","endTime":"0","summary":"Medpace控股公司（Medpace Holdings, Inc.）宣布，计划于2026年2月9日发布其2025财年第四季度及全年财务报告。此次披露将全面展示公司在第四季度的经营表现以及整个财年的整体财务健康状况。投资者和市场分析师正密切关注这份报告，以期深入了解Medpace在临床研究领域的最新进展和未来展望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP","LU2065169927.USD","LU2065170008.USD","BK4588","BK4121","LU2065171311.SGD","BK4585","LU2065171402.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586441988","title":"Medpace Holdings, Inc.涨1.68% 股价突破600美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2586441988","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586441988?lang=zh_cn&edition=full","pubTime":"2025-11-24 23:04","pubTimestamp":1763996677,"startTime":"0","endTime":"0","summary":"北京时间2025年11月24日23时04分，Medpace Holdings, Inc.股票出现波动，股价快速拉升1.68%。Medpace Holdings, Inc.股票所在的生命科学行业中，整体跌幅为0.17%。Medpace Holdings, Inc.公司简介：Medpace是一家后期阶段的合同研究组织，为小型和中型生物技术、制药和医疗器械公司提供全方位的药物开发和临床试验服务。全球私募股权公司Cinven于2014年以9.15亿美元收购Medpace，并于2018年退出其投资。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511242304379517b1cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511242304379517b1cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065171311.SGD","BK4121","LU2065171402.SGD","LU2065170008.USD","MEDP","BK4588","LU2065169927.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2578229675","title":"Medpace Holdings, Inc.跌0.87% 股价跌破600美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2578229675","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578229675?lang=zh_cn&edition=full","pubTime":"2025-10-27 21:34","pubTimestamp":1761572097,"startTime":"0","endTime":"0","summary":"北京时间2025年10月27日21时34分，Medpace Holdings, Inc.股票出现异动，股价大幅跳水0.87%。Medpace Holdings, Inc.股票所在的生命科学行业中，整体跌幅为0.17%。Medpace Holdings, Inc.公司简介：Medpace是一家后期合同研究组织，为小型和中型生物技术、制药和医疗器械公司提供全方位的药物开发和临床试验服务。全球私募股权公司Cinven于2014年以9.15亿美元收购Medpace，并于2018年退出其投资。消息层面，截至21时34分，《贝雅维持Medpace持有评级，上调目标价至613美元》资讯为影响Medpace Holdings, Inc.的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251027213457a477c776&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251027213457a477c776&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065171311.SGD","LU2065171402.SGD","BK4585","LU2065169927.USD","MEDP","BK4588","LU2065170008.USD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165119381","title":"异动解读 | Medpace盘前大涨18.52%，第三季度业绩远超预期且上调全年展望","url":"https://stock-news.laohu8.com/highlight/detail?id=1165119381","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165119381?lang=zh_cn&edition=full","pubTime":"2025-10-23 20:04","pubTimestamp":1761221078,"startTime":"0","endTime":"0","summary":"合同研究组织公司Medpace Holdings Inc.今日盘前股价大涨18.52%，引起市场广泛关注。这一显著涨幅主要源于公司发布的第三季度财报远超市场预期，并上调了全年业绩展望。根据Medpace公布的最新财务报告，公司第三季度业绩表现亮眼。作为一家领先的合同研究组织，Medpace为生物制药、医疗器械和诊断行业提供全面的临床开发服务。分析人士认为，Medpace的优异表现可能预示着生物医药研发行业的持续繁荣，值得投资者持续关注。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185722291","title":"异动解读 | 业绩远超预期，Medpace盘前大涨18.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=1185722291","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185722291?lang=zh_cn&edition=full","pubTime":"2025-10-23 20:04","pubTimestamp":1761221059,"startTime":"0","endTime":"0","summary":"周四盘前，Medpace Holdings Inc.股价大幅上涨18.52%，引发市场广泛关注。这一显著涨幅主要源于公司发布的第三季度财报远超市场预期。根据Medpace公布的最新财务报告，公司第三季度业绩表现亮眼。此前，市场预期Medpace的每股收益为3.53美元，营收为6.4099亿美元。作为一家领先的合同研究组织，Medpace为生物制药、医疗器械和诊断行业提供全面的临床开发服务。在这些利好因素的推动下，Medpace的股价在盘前交易中出现了显著上涨。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1145687641","title":"异动解读 | Medpace夜盘大涨18.90%，第三季度业绩远超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1145687641","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145687641?lang=zh_cn&edition=full","pubTime":"2025-10-23 15:10","pubTimestamp":1761203438,"startTime":"0","endTime":"0","summary":"Medpace Holdings Inc.在夜盘交易中股价大幅上涨18.90%，引起了市场的广泛关注。这一显著涨幅主要源于公司发布的第三季度财报远超市场预期。根据Medpace公布的最新财务报告，公司第三季度业绩表现亮眼。这两项关键指标均远超分析师预期。此前，市场预期Medpace的每股收益为3.53美元，营收为6.4099亿美元。作为一家领先的合同研究组织，Medpace为生物制药、医疗器械和诊断行业提供全面的临床开发服务。在这些利好因素的推动下，Medpace的股价在夜盘交易中出现了显著上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1109043314","title":"美股夜盘 | 特朗普政府考虑入股，量子计算概念股飙升；“妖股”BYND跌超15%！VTYX飙升83%","url":"https://stock-news.laohu8.com/highlight/detail?id=1109043314","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109043314?lang=zh_cn&edition=full","pubTime":"2025-10-23 08:54","pubTimestamp":1761180878,"startTime":"0","endTime":"0","summary":"10月23日，美股夜盘时段，$特斯拉$跌超3%，Q3营收同比增长12%，但盈利超预期猛降31%。$Beyond Meat$夜盘跌超15%，隔夜一度涨逾110%后转跌。$Molina Healthcare$夜盘大跌18%，每股收益不及预期。美股量子计算概念股夜盘拉升，QBTS涨超14%，RGTI涨超11%，QUBT涨超7%；据华尔街日报报道，美国总统特朗普政府正商谈入股量子计算公司。$Medpace$夜盘涨超18%，Q3营收同比增长23.7%，全年展望上调。$Ventyx Biosciences$夜盘飙升83%，VTX3232联合司美格鲁肽时疗效增强。$美国铝业$Q3销售额30亿美元，不及市场预期","market":"us","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"bc3e4efb84c9072c92933bdae3fafd6b","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1914381329.SGD","LU2360107168.USD","LU1880398471.USD","LU1861215975.USD","LU0823414478.USD","LU2471134523.USD","LU0316494557.USD","LU0820561818.USD","BK4604","LU1366192091.USD","BK4598","LU1883839398.USD","IE00BK4W5L77.USD","BK4538","LU0345769128.USD","LU2063271972.USD","LU1066051498.USD","BK4555","LU2249611893.SGD","LU2896262040.SGD","BK4212","BK4581","LU0234570918.USD","BK4579","LU0719512351.SGD","SG9999015952.SGD","LU1720051017.SGD","LU1674673428.USD","LU2108987350.USD","LU1585245621.USD","BK4548","LU1232071149.USD","LU2360106780.USD","BK4550","LU1066051225.USD","LU0097036916.USD","LU2756315664.SGD","IE00B19Z9505.USD","LU0082616367.USD","LU2250418816.HKD","LU0323591593.USD","LU2290526834.HKD","LU0689472784.USD","LU1145028129.USD","LU1861558580.USD","LU1551013342.USD","LU1839511570.USD","LU0348723411.USD","SG9999015986.USD","BK4585","IE00B1XK9C88.USD","LU0820562030.AUD","BK4602","BK4574","QS","LU0053666078.USD","LU1066051811.HKD","LU1066053197.SGD","BK4099","LU0345770308.USD","IE00BJLML261.HKD","LU0823411888.USD","LU0056508442.USD","BK4516","LU0321505868.SGD","LU0345770993.USD","TSLA","BK4575","LU2471134879.HKD","LU2750360997.AUD","LU0964807845.USD","IBM","SG9999015945.SGD","LU2326559502.SGD","LU0868494617.USD","BK4543","MEDP","LU2471134796.USD","BK4533","LU1548497426.USD","LU1861220033.SGD","LU1435385759.SGD","LU1880398554.USD","IE00B1BXHZ80.USD","LU0345769631.USD","LU1551013425.SGD","LU2602419157.SGD","LU0466842654.USD","LU0321505439.SGD","BK4588","LU1778281490.HKD","LU1629891620.HKD","IE0034235303.USD","LU0234572021.USD","LU1852331112.SGD","LU0943347566.SGD","BK4612","LU0198837287.USD","LU0077335932.USD","BK4592","LU2023250330.USD","LU1861559042.SGD","BK4511","LU1674673691.USD","LU2357305700.SGD","SG9999015978.USD","LU0820561909.HKD","BK4534","LU1430594728.SGD","IE00BK4W5M84.HKD","BK4527","LU0210536198.USD","LU2750360641.GBP","LU2471134952.CNY","IE00BSNM7G36.USD","LU2213496289.HKD","LU2087621335.USD","LU2756315318.SGD","BYND","LU1429558221.USD","LU1720051108.HKD","BK4551","BK4134","IE00B19Z8W00.USD","IE00BWXC8680.SGD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1121292365","title":"异动解读 | Medpace股价夜盘大涨17.06%，第三季度业绩远超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1121292365","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121292365?lang=zh_cn&edition=full","pubTime":"2025-10-23 08:16","pubTimestamp":1761178587,"startTime":"0","endTime":"0","summary":"周三夜盘交易中，Medpace Holdings Inc.股价大幅上涨17.06%，引起投资者广泛关注。这一显著涨幅主要归因于公司发布的第三季度财报超出市场预期。根据Medpace公布的最新财务报告，公司第三季度每股收益达到3.86美元，总营收为6.599亿美元。Medpace的优异业绩表现无疑增强了投资者对公司未来发展前景的信心。作为一家领先的合同研究组织，Medpace为生物制药、医疗器械和诊断行业提供全面的临床开发服务。投资者对此反应热烈，推动Medpace股价在盘后交易中大幅上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1180318496","title":"Medpace Q3 每股收益及营收超出预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1180318496","media":"英为财情","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180318496?lang=zh_cn&edition=full","pubTime":"2025-10-23 08:13","pubTimestamp":1761178400,"startTime":"0","endTime":"0","summary":"Medpace (NASDAQ: MEDP)星期三发布了第三季度的财报，数据显示，公司营收高于分析师的预期，每股收益超出了分析师的预期。在该公司发布的最新财报中，公司每股收益为$3.86，总营收为$659.9M，而此前英为财情Investing.com对分析师的调查显示，分析师预期该公司的营收为$640.99M，每股收益为$3.53.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":{"source":"lsy1594375853987","url":"https://m.cn.investing.com/news/earnings/article-3039053?ampMode=1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://m.cn.investing.com/news/earnings/article-3039053?ampMode=1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Medpace Q3 每股收益及营收超出预期","news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1594375853987","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2574874804","title":"Medpace Holdings, Inc.跌3.60% 股价跌破500美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2574874804","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574874804?lang=zh_cn&edition=full","pubTime":"2025-10-11 00:36","pubTimestamp":1760114199,"startTime":"0","endTime":"0","summary":"北京时间2025年10月11日00时36分，Medpace Holdings, Inc.股票出现波动，股价大幅跳水3.60%。Medpace Holdings, Inc.股票所在的生命科学行业中，整体跌幅为1.41%。Medpace Holdings, Inc.公司简介：Medpace是一家后期合同研究组织，为小型和中型生物技术、制药和医疗器械公司提供全方位的药物开发和临床试验服务。全球私募股权公司Cinven于2014年以9.15亿美元收购Medpace，并于2018年退出其投资。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251011003640a6b33a18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251011003640a6b33a18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065171402.SGD","LU2065169927.USD","MEDP","LU2065170008.USD","BK4121","LU2065171311.SGD","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514063909","title":"盟科药业：全资子公司盟科美国对Medpace提起诉讼","url":"https://stock-news.laohu8.com/highlight/detail?id=2514063909","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514063909?lang=zh_cn&edition=full","pubTime":"2025-02-25 16:52","pubTimestamp":1740473555,"startTime":"0","endTime":"0","summary":"每经AI快讯，2月25日，盟科药业公告称，公司全资子公司盟科美国于2025年2月24日收到美国俄亥俄州南区联邦地区法院西部分院起诉立案确认通知，盟科美国诉Medpace合同纠纷一案已完成起诉立案。盟科美国请求判令Medpace赔偿因违反合同义务和不当行为导致的损失、成本和费用以及利息，具体金额将在庭审中证明。目前案件尚未开庭审理，最终实际影响需以后续法院判决或执行结果为准。公司已完成注射用MRX-4的中国III期临床试验，本次诉讼事宜不涉及对该试验的影响。文章来源：每日经济新闻原标题：盟科药业：全资子公司盟科美国对Medpace提起诉讼","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225170609a2532c26&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225170609a2532c26&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2065171402.SGD","BK4588","BK4585","MEDP","LU2065171311.SGD","LU2065170008.USD","LU2065169927.USD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511692167","title":"Medpace Holdings, Inc.2024财年实现净利润4.04亿美元，同比增加42.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511692167","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511692167?lang=zh_cn&edition=full","pubTime":"2025-02-15 00:00","pubTimestamp":1739548835,"startTime":"0","endTime":"0","summary":"2月15日，Medpace Holdings, Inc.公布财报，公告显示公司2024财年净利润为4.04亿美元，同比增加42.76%；其中营业收入为21.09亿美元，同比增加11.82%，每股基本收益为13.06美元。从资产负债表来看，Medpace Holdings, Inc.总负债12.75亿美元，其中短期债务23.29百万美元，资产负债比为1.65，流动比率为0.94。机构评级：截至2025年2月15日，当前有8家机构对Medpace Holdings, Inc.目标价做出预测，其中目标均价为354.38美元，其中最低目标价为300.00美元，最高目标价为400.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215000055a246151e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215000055a246151e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510312861","title":"净利润飙升50%！CRO龙头Q4业绩公布","url":"https://stock-news.laohu8.com/highlight/detail?id=2510312861","media":"生物药大时代","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510312861?lang=zh_cn&edition=full","pubTime":"2025-02-12 11:53","pubTimestamp":1739332418,"startTime":"0","endTime":"0","summary":"近日，海外CRO龙头Medpace公布2024年业绩：截至 2024 年 12 月 31 日止，全年收入21.09亿美元，同比增长11.8% 。其中Q4营收5.366 亿美元，同比增长7.7%，积压订单转化率为 18.3%。值得注意的是，Q4净利润激增50％到1.17 亿美元；全年净利润大增43%至4.04亿美元。截至 2025 年 2 月 12 日，其总市值达 109.9 亿美元。自上市以来，该公司表现较为亮眼，上市 8 年间股价大涨超 1600%，并在 2024 年 7 月 17 日创下 459.77 美元的历史新高水平 。目前，全球约有一千多家 CRO 机构，大型企业占据主导地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212140209abcbd90e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212140209abcbd90e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510803443","title":"Medpace Holdings, Inc.盘中异动 急速跳水6.35%报332.01美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510803443","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510803443?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:31","pubTimestamp":1739284268,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时31分，Medpace Holdings, Inc.股票出现异动，股价大幅下挫6.35%。截至发稿，该股报332.01美元/股，成交量2.1873万股，换手率0.07%，振幅0.62%。Medpace Holdings, Inc.股票所在的生命科学行业中，整体跌幅为0.46%。Medpace Holdings, Inc.公司简介：Medpace 是一家成立超过30年的晚期合同研究组织，为中小型生物技术、制药和医疗器械公司提供全方位的药物开发和临床试验服务。全球私募股权公司Cinven于2014年以9.15亿美元收购了Medpace，并于2018年退出了投资。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223108961f476f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223108961f476f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEDP","LU2065171311.SGD","LU2065169927.USD","BK4121","LU2065170008.USD","BK4588","BK4585","LU2065171402.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118312283","title":"Medpace Hldgs 2024年第四季度GAAP每股收益3.67美元超出预期的2.96美元，销售额5366万美元击败预期的5347.82万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1118312283","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118312283?lang=zh_cn&edition=full","pubTime":"2025-02-11 05:18","pubTimestamp":1739222313,"startTime":"0","endTime":"0","summary":"Medpace Hldgs 2024年第四季度GAAP每股收益3.67美元超出预期的2.96美元，销售额5366万美元击败预期的5347.82万美元。以上内容来自Benzinga Earnings专栏，原文如下：Medpace Hldgs Q4 2024 GAAP EPS $3.67 Beats $2.96 Estimate, Sales $536.6M Beat $534.782M Estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Medpace Hldgs 2024年第四季度GAAP每股收益3.67美元超出预期的2.96美元，销售额5366万美元击败预期的5347.82万美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509726492","title":"Medpace Holdings, Inc.盘中异动 早盘股价大涨5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509726492","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509726492?lang=zh_cn&edition=full","pubTime":"2025-02-06 22:34","pubTimestamp":1738852456,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日22时34分，Medpace Holdings, Inc.股票出现异动，股价快速上涨5.46%。Medpace Holdings, Inc.股票所在的生命科学行业中，整体涨幅为0.32%。Medpace Holdings, Inc.公司简介：Medpace 是一家成立超过30年的晚期合同研究组织，为中小型生物技术、制药和医疗器械公司提供全方位的药物开发和临床试验服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223417987c8f40&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206223417987c8f40&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","LU2065170008.USD","BK4588","BK4585","LU2065169927.USD","MEDP","LU2065171311.SGD","LU2065171402.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506630049","title":"Baird：维持Medpace Hldgs(MEDP.US)评级，由中性调整至中性评级, 目标价由354.00美元调整至362.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2506630049","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506630049?lang=zh_cn&edition=full","pubTime":"2025-01-28 01:20","pubTimestamp":1737998456,"startTime":"0","endTime":"0","summary":"Baird：维持Medpace Hldgs(MEDP.US)评级，由中性调整至中性评级, 目标价由354.00美元调整至362.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/28012047864398.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504449484","title":"特朗普2.0时代即将开启，投资机会如何掘金？","url":"https://stock-news.laohu8.com/highlight/detail?id=2504449484","media":"招商基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504449484?lang=zh_cn&edition=full","pubTime":"2025-01-20 10:36","pubTimestamp":1737340585,"startTime":"0","endTime":"0","summary":"美国候任总统唐纳德·特朗普将于美东时间1月20日12时正式宣誓就任美国第47任总统。特朗普2.0时代即将开启，有哪些投资机会可以布局？值得一提的是，科技股在特朗普任期内表现尤为突出，成为推动美股上涨的主要力量。在特朗普第一个任期内，美元整体表现相对弱势。4年任期内，美元指数累计下跌了10.53%。而纵观全球市场，在特朗普上一任期内，恒生科技指数涨幅超过147%，表现甚至略微优于纳斯达克指数。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120103318abb12e8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120103318abb12e8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WYNN","MIDD","AMZN","TER","JBHT","FYBR","SAIA","JKHY","NDAQ","EXE","REGN","SFM","MEDP","MRNA","TLN","CDNS","COKE","CHRW","NTRS","NXPI","ALGN","ISRG","WTFC","FCNCA","ICLR","GOOGL","MSFT","EBAY","LNT","ALNY","SOFI","STX","ASML","POOL","NBIX","TPG","PSQ","Z","PAA",".IXIC","CDW","CSWI","ERIE","NDSN","MNQmain","NVMI","FWONK","ADBE","GTLB","INCY","TTEK","SSNC","LULU","TROW","FRPT","CHRD","DLTR","GMAB","QQQ","FSLR","LIN","SNPS","TW","MARA","WBA","MCHP","ODFL","QLD","ZM","NTAP","SWKS","PAYX","NVDA","SQQQ","MTCH","RPRX","TCOM","WWD","BSY","AMAT","MANH","DASH","RIVN","FTNT","INTU","HST","RADX","IDXX","CHKP","TSEM","AVGO","CSCO","REG","TMUS","AZN","LU1815336091.USD","CG","TRMB","BIIB","ZS","ADI","CHDN","CFLT","USAW.SI","FFIV","LI","LSTR","BK4561","CPB","ERIC","AFRM","LU0757428866.USD","SBUX","HBAN","TXN","TEAM","EXAS","CWST","JD","NTNX","QXO","BKR","GRAB","CPRT","MELI","ONC","ROKU","BKNG","WDC","ALAB","MTSI","PCAR","ENTG","NTES","PEP","ARGX","PODD","CZR","RGEN","GEN","CTAS","MMYT","ITCI","DUOL","ULTA","META","HSIC","SBAC","BMRN","ROP","FOX","ROIV","CSX","CASY","TTWO","CSGP","USJW.SI","ARM","INTC","MPWR","AXON","GILD","FSV","MDB","AAON","AGNC","DOCU","ADSK","CINF","TSYW.SI","EWBC","AMD","QID","AAPL","ESLT","LECO","LU2065731478.USD","CHTR","BK4585","CRWD","BK4581","NVIW.SI","ROST","TQQQ","NFLX","RVMD","AMGN","PCTY","HQY","HON","HTHT","EVRG","NTRA","ENPH","PNFP","AUR","QCOM","FER","LKQ","KDP","INSM","GNTX","DDOG","BPMC","SRPT","EA","PARA","RYAAY","CTSH","RKLB","PLTR","BRKR","LOGI","ANSS","CBSH","FAST","AAL","BK4086","DOX","KHC","COST","HOOD","SEIC","TSCO","PCVX","NQmain","EQIX","BK4550","ON","TSLA","CEG","ORLY","BK4534","AKAM","CYBR","FOXA","HLNE","HOLX","NWSA","TTD","MKSI","BK4588","STLD","EXPE","COIN","DKNG","OKTA","SIRI","RGLD","APA","DPZ","MKTX","SMCI","ILMN","TECH","LNW","GEHC","NICE","PDD","PFG","OTEX","DSGX","GLPI","CME","LU0053671581.USD","OLED","MDLZ","MNDY","PTC","LPLA","LSCC","BPOP","BK4593","AEP","LAMR","MRVL","QRVO","FTAI","CCEP","MNST","COO"],"isVideo":false,"video":null,"gpt_icon":1}],"profile":{"websiteUrl":"http://www.medpace.com","stockEarnings":[{"period":"1week","weight":0.0074},{"period":"1month","weight":0.0189},{"period":"3month","weight":-0.1908},{"period":"6month","weight":-0.1537},{"period":"1year","weight":0.4736},{"period":"ytd","weight":-0.1805}],"compareEarnings":[{"period":"1week","weight":-0.0357},{"period":"1month","weight":-0.0787},{"period":"3month","weight":-0.0801},{"period":"6month","weight":-0.0546},{"period":"1year","weight":0.1373},{"period":"ytd","weight":-0.0732}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Medpace Holdings, Inc.于2014年2月18日在美国特拉华州注册成立，是全球领先的临床合同研究组织（CRO）之一，专注于为生物技术、制药和医疗器械行业提供以科学为导向的外包临床开发服务。公司提供覆盖I至IV期的全流程临床开发服务，在肿瘤学、代谢疾病、心脏病学、抗病毒与抗感染（AVAI）以及中枢神经系统（CNS）等治疗领域具有突出优势。Medpace业务遍及所有主要治疗领域，凭借其规范化的运营模式，致力于为中小型生物制药公司提供及时、高质量且具成本效益的临床试验服务，从而成为其优先合作对象。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.006402},{"month":2,"riseRate":0.3,"avgChangeRate":-0.035449},{"month":3,"riseRate":0.7,"avgChangeRate":0.002513},{"month":4,"riseRate":0.666667,"avgChangeRate":0.005652},{"month":5,"riseRate":0.444444,"avgChangeRate":0.020283},{"month":6,"riseRate":1,"avgChangeRate":0.07437},{"month":7,"riseRate":0.666667,"avgChangeRate":0.148095},{"month":8,"riseRate":0.666667,"avgChangeRate":0.032832},{"month":9,"riseRate":0.6,"avgChangeRate":-0.004448},{"month":10,"riseRate":0.5,"avgChangeRate":0.057543},{"month":11,"riseRate":0.7,"avgChangeRate":0.057867},{"month":12,"riseRate":0.7,"avgChangeRate":0.025222}],"exchange":"NASDAQ","name":"Medpace Holdings Inc.","nameEN":"Medpace"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Medpace Holdings Inc.(MEDP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Medpace Holdings Inc.(MEDP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Medpace Holdings Inc.,MEDP,Medpace Holdings Inc.股票,Medpace Holdings Inc.股票老虎,Medpace Holdings Inc.股票老虎国际,Medpace Holdings Inc.行情,Medpace Holdings Inc.股票行情,Medpace Holdings Inc.股价,Medpace Holdings Inc.股市,Medpace Holdings Inc.股票价格,Medpace Holdings Inc.股票交易,Medpace Holdings Inc.股票购买,Medpace Holdings Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Medpace Holdings Inc.(MEDP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Medpace Holdings Inc.(MEDP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}